Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

'Gutter Snan' For Aman Gupta; Instagram User Calls Him 'Fraud', Alleges Financial Irregularities...

'Gutter Snan' For Aman Gupta; Instagram User Calls Him 'Fraud', Alleges Financial Irregularities...

GST Reduction To Cut Consumer Price Index Inflation By 25 Basis Points, Could Reduce 35 BSP: SBI...

GST Reduction To Cut Consumer Price Index Inflation By 25 Basis Points, Could Reduce 35 BSP: SBI...

Government-Supported AIFs Invest ₹2,839 Crore In 154 Women-Led Startups

Government-Supported AIFs Invest ₹2,839 Crore In 154 Women-Led Startups

Insurance Laws Amendment Bill, 2025, Which Raised FDI Limit To 100%, Will Attract Capital & Support...

Insurance Laws Amendment Bill, 2025, Which Raised FDI Limit To 100%, Will Attract Capital & Support...

India Remains A Bright Spot Amid Global Uncertainty, With Robust 6.5% Growth Rate & Strong Domestic...

India Remains A Bright Spot Amid Global Uncertainty, With Robust 6.5% Growth Rate & Strong Domestic...